Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Warning Letter
  6. /
  7. RiteAid Corporation
WARNING LETTER
•RiteAid Corporation•October 25, 2022

RiteAid Corporation – FDA Warning Letter, Oct 25, 2022

Record Details

The FDA issued a Warning Letter to Ms. Horton regarding discrepancies in the drug listing information for "Mucus Relief DM, NDC 11822-7224." The electronic listing file includes phenylephrine hcl as an active ingredient, which is not present on the submitted labeling. This constitutes a violation of Section 510(j) of the FD&C Act and 21 CFR 207, which require accurate listing of all active pharmaceutical ingredients.

The FDA previously notified the firm of these deficiencies on December 6, 2021, and subsequently removed the product from FDA’s Online NDC Directory on January 20, 2022, due to continued non-compliance. Failure to properly list a drug also renders it misbranded under Section 502(o) and a prohibited act under Section 301(a) and 301(p) of the FD&C Act.

The FDA emphasizes that complete and accurate drug listing information is crucial for patient safety, drug establishment inspections, supply chain security, and post-market surveillance. The firm is required to investigate and correct the violations, and prevent recurrence. A written response detailing corrective actions, including supporting documentation, must be submitted to the FDA within 15 working days. Failure to address the matter may result in legal action, including seizure and injunction.

Company
RiteAid Corporation
Inspection date
October 25, 2022
Product type
Drugs
Office
Center for Drug Evaluation and Research
Person
  • Carolyn E. Becker
View Company Profile

ID · bed9b515-0096-4d55-8795-879a36142de3

Violation Codes6
21 CFR 207FD&C Act 510(j)21 U.S.C. 36021 U.S.C. 331(p)21 U.S.C. 352(o)21 U.S.C. 331(a)

Full citation text and observation details available on the Dashboard.

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore RiteAid Corporation
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.